These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35081015)

  • 21. Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma.
    Faridi UA; Saleh TA; Ewings P; Venkateswaran M; Cadman DH; Samarasinghe RA; Vodden J; Claridge KG
    Clin Exp Ophthalmol; 2010 Oct; 38(7):678-82. PubMed ID: 20456437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide [ISRCTN18873428].
    Zeitz O; Matthiessen ET; Reuss J; Wiermann A; Wagenfeld L; Galambos P; Richard G; Klemm M
    BMC Ophthalmol; 2005 Apr; 5():6. PubMed ID: 15811188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs.
    Inoue K; Shiokawa M; Wakakura M; Tomita G
    J Glaucoma; 2013; 22(8):626-31. PubMed ID: 22936280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral upper eyelid retraction caused by topical bimatoprost therapy.
    Noma K; Kakizaki H
    Ophthalmic Plast Reconstr Surg; 2012; 28(2):e33-5. PubMed ID: 21562439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deepening of lid sulcus from topical bimatoprost therapy.
    Peplinski LS; Albiani Smith K
    Optom Vis Sci; 2004 Aug; 81(8):574-7. PubMed ID: 15300114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
    Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
    Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacology of bimatoprost.
    Cantor LB
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):151-7. PubMed ID: 16922657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bimatoprost, prostamide activity, and conventional drainage.
    Wan Z; Woodward DF; Cornell CL; Fliri HG; Martos JL; Pettit SN; Wang JW; Kharlamb AB; Wheeler LA; Garst ME; Landsverk KJ; Struble CS; Stamer WD
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4107-15. PubMed ID: 17724194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased orbital fat and enophthalmos due to bimatoprost: Quantitative analysis using magnetic resonance imaging.
    Higashiyama T; Minamikawa T; Kakinoki M; Sawada O; Ohji M
    PLoS One; 2019; 14(3):e0214065. PubMed ID: 30917168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Receptors involved in the mechanism of action of topical prostaglandines].
    Neacsu AM
    Oftalmologia; 2009; 53(2):3-7. PubMed ID: 19697832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of cutaneous prostaglandin application on nail growth, nail brittleness, and intraocular pressure.
    Palmer DJ; Scheman A; Tanna AP; Bueno A
    J Cosmet Dermatol; 2018 Apr; 17(2):263-267. PubMed ID: 28681570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
    Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.
    Reardon G; Schwartz GF; Mozaffari E
    Clin Ther; 2003 Apr; 25(4):1172-85. PubMed ID: 12809964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of the effect of bimatoprost/timolol fixed combination on ocular blood flow in patients with ocular hypertension using colour Doppler imaging. Preliminary study].
    García-Pérez JL; Puerto-Hernández B; Rebolleda Fernández G; Muñoz-Negrete FJ; González-Gordaliza C
    Arch Soc Esp Oftalmol; 2010 Apr; 85(4):131-7. PubMed ID: 20858400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN or TRAVATAN.
    Faulkner R; Sharif NA; Orr S; Sall K; Dubiner H; Whitson JT; Moster M; Craven ER; Curtis M; Pailliotet C; Martens K; Dahlin D
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):147-56. PubMed ID: 20307216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical bimatoprost 0.03% and iatrogenic eyelid and orbital lipodystrophy.
    Sira M; Verity DH; Malhotra R
    Aesthet Surg J; 2012 Sep; 32(7):822-4. PubMed ID: 22942109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the protective effects of prostaglandin analogues in the ischemia and reperfusion model of rabbit eyes.
    Emre S; Gul M; Ates B; Esrefoglu M; Koc B; Erdogan A; Yesilada E
    Exp Anim; 2009 Oct; 58(5):505-13. PubMed ID: 19897934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma.
    Berenson KL; Kymes S; Hollander DA; Fiscella R; Burk C; Patel VD
    Am J Manag Care; 2011 Sep; 17(9):e365-74. PubMed ID: 21902444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
    Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
    Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide.
    Richter M; Krauss AH; Woodward DF; Lütjen-Drecoll E
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4419-26. PubMed ID: 14507888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.